Home › Facility Concerns Kill Lilly-Boehringer Diabetes Drug
 

Keywords :   


Facility Concerns Kill Lilly-Boehringer Diabetes Drug

2014-03-05 22:15:21| Agriculture - Topix.net

Eli Lilly and Boehringer-Ingelheim said that the Food and Drug Administration didn't approve their diabetes treatment empagliflozin because of concerns about a facility where the drug will be made.

Tags: drug concerns facility kill

Category:Agriculture and Forestry

Latest from this category

All news
22.11Trump expected to tab Kelly Loeffler for Secretary of Agriculture
22.11Hay supply is likely up, but winter feed costs still matter
22.11Future plans for US SHIP and USDA's role explored
22.11Strategy for increasing feed efficiency for cows
22.11Top 3 myths of cattle marketing
22.11Carcass management workshop gets pork producers FAD prepared
22.11Are we close to eliminating Mycoplasma hyopneumoniae from the U.S. swine herd?
22.11Costa to challenge Scott for top House Agriculture Democrat role
Agriculture and Forestry »
23.11PlayStationVitaPCH-2000
23.11GB
23.11 Malbon
23.11PING PEARL GATES
23.11WATCH
23.11L
23.11Tetsuya_SP2 DMC
23.116
More »